- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.07. | AbbVie files to move Venclexta combo into the CLL front line | ||
| 30.07. | AI picks up interval breast cancers missed by scans | ||
| 30.07. | GSK suffers a setback with its TIM-3 programme | ||
| 30.07. | White House retreats from block on NIH research funding | ||
| 30.07. | Vinay Prasad abruptly departs from the FDA | ||
| 29.07. | Novo Nordisk slumps as it cuts sales forecast, names new CEO | ||
| 29.07. | MSD trims outlook as it aims to shave $3bn off costs | ||
| 29.07. | FDA gives the go-ahead to restart Elevidys shipments | ||
| 29.07. | Pharma tariffs set to arrive with US-EU trade deal | ||
| 29.07. | Celcuity eyes big market opportunity after breast cancer win | ||
| 28.07. | Bayer files HER2+ lung cancer drug in China | ||
| 28.07. | UK biotech investment "holding firm", says BIA | ||
| 28.07. | Roche expands phase 3 plans for Alzheimer's drug | ||
| 28.07. | Lilly's appeal unlocks EU approval of Alzheimer's drug | ||
| 28.07. | GSK forges $12bn alliance with China's Hengrui | ||
| 25.07. | UK MHRA green lights AbbVie's ELAHERE for ovarian cancer | ||
| 25.07. | Boehringer eyes H2 drug launches after strong H1 growth | ||
| 24.07. | GSK adds EU to Blenrep checklist as FDA sets new PDUFA date | ||
| 24.07. | AZ boasts phase 3 win for self-administered gMG drug | ||
| 24.07. | mRNA 'wake-up call' shows promise as universal cancer vaccine | ||
| 24.07. | EC clears first treatment for high-risk smouldering multiple myeloma | ||
| 24.07. | RFK Jr formally backs thimerosal ban in US vaccines | ||
| 23.07. | European Commission approves 2nd IPCEI to sum of €403m | ||
| 23.07. | AI health tech Respiree closes $11.6m Series A | ||
| 23.07. | Replimune receives CRL on BLA for RP1 for advanced melanoma |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .